Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
Journal
-
- The Lancet Oncology
-
The Lancet Oncology 14 (10), 953-961, 2013-09
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1362262945546569344
-
- ISSN
- 14702045
-
- Data Source
-
- Crossref